Why the study?
Does intracoronary nicardipine reduce periprocedural myonecrosis in low-risk patients undergoing elective PCI?
Does intracoronary nicardipine reduce periprocedural myonecrosis in low-risk patients undergoing elective PCI?
Intracoronary nicardipine administration prior to elective PCI does not significantly reduce postprocedural cardiac enzyme leakage in low-risk patients.
No takes yet. Share an insight, caveat, or question.
Does not support routine intracoronary nicardipine in low-risk elective PCI; confirms neutral effect and discourages adjunctive use.
Arora et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: